Market Cap
¥11.542 Trillion
JPY as of July 1, 2025
US$80.50 Billion
| Company | Market Cap (USD) | 
|---|---|
|  Lilly | $699.59 B | 
|  Johnson & Johnson | $374.29 B | 
|  AbbVie | $336.94 B | 
|  Roche | $260.54 B | 
|  Novartis | $243.50 B | 
| Company | Market Cap (USD) | 
|---|---|
|  Lilly | $699.59 B | 
|  Johnson & Johnson | $374.29 B | 
|  AbbVie | $336.94 B | 
|  Novo Nordisk | $309.91 B | 
|  UnitedHealth Group | $279.90 B | 
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
 Japan
                        
                    
                    
                        languages
                        Healthcare
                    
                        languages
                        Drug Manufacturers—General
                            Japan
                        
                    
                    
                        languages
                        Healthcare
                    
                        languages
                        Drug Manufacturers—General
                     Japan Healthcare
                                Japan Healthcare
                        
                             Japan Drug Manufacturers—General
                            Japan Drug Manufacturers—General
                    
                    Chugai Pharmaceutical Co. Ltd has the following listings and related stock indices.
Stock: JPX: 4519
Stock: FSX: CUP
Stock: OTC: CHGCF
Stock: OTC: CHGCY
The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.